MRKR insider transaction filings
Marker Therapeutics, Inc. — 11 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-11-19. Screen MRKR transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for MRKR between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Marker Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-11-19 | 4 | Knobil Katharine — Director | Grant/award (A): 84,411 (derivative) @ $0 · Grant/award (A): 137,330 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | Eansor Norman David — Director | Grant/award (A): 84,411 (derivative) @ $0 · Grant/award (A): 137,330 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | ELMS STEVE — Director | Grant/award (A): 84,411 (derivative) @ $0 · Grant/award (A): 137,330 (derivative) @ $0 | EDGAR |
| 2025-11-04 | 4 | Corzo Kathryn Penkus — Director | Grant/award (A): 147,611 (derivative) @ $0 | EDGAR |
| 2025-11-04 | 4 | Vera Juan — Chief Executive Officer, Director | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | ELMS STEVE — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Knobil Katharine — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Eansor Norman David — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Vera Juan — President and CEO, Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-12-26 | 4 | ELMS STEVE — Director | Purchase (P): 11,085 @ $3.20 | EDGAR |
| 2024-12-23 | 4 | New Enterprise Associates 16, L.P. — 10% owner NEA Partners 16, L.P. — 10% owner NEA 16 GP, LLC — 10% owner BASKETT FOREST — 10% owner Chang Carmen — 10% owner Behbahani Ali — 10% owner Florence Anthony A. Jr. — 10% owner Makhzoumi Mohamad — 10% owner SANDELL SCOTT D — 10% owner Walker Paul Edward — 10% owner | Purchase (P): 554,250 @ $3.20 | EDGAR |
Recent 8-K events — Marker Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-05-04 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-19 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-09 | 8-K | ? 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-26 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-12 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-09 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MRKR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →